Literature DB >> 1707697

The majority of peripheral blood monoclonal IgM secreting cells are CD5 negative in three patients with mixed cryoglobulinemia.

J L Pasquali1, C Waltzinger, J L Kuntz, A M Knapp, H Levallois.   

Abstract

The mixed cryoglobulinemia is considered to be a nonmalignant human B-cell proliferation that frequently produces a monoclonal IgM with anti-IgG activity (rheumatoid factor). Using murine monoclonal anti-idiotypic antibodies specific for private or minor idiotopes on monoclonal IgM from three patients suffering from nonmalignant mixed cryoglobulinemia, we investigated the presence of the CD5 antigen on the monoclonal IgM producing cells in these patients. It is shown by two-color cytofluorometric analysis that the majority of the peripheral blood monoclonal IgM rheumatoid factor secreting cells is CD5 negative in these three patients. One of the monoclonal rheumatoid factor K variable regions was sequenced at the protein level and belongs to the human VK III group, as a high proportion of monoclonal rheumatoid factors and some B-cell chronic lymphocytic leukemia (CLL) membrane bound Igs. Thus, despite the preferential use of similar VK genes and the absence of somatic mutation affecting these variable regions in both malignant B-cell CLL and nonmalignant mixed cryoglobulinemia, these proliferating B cells differ in the CD5 membrane expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707697

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

Review 1.  The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients.

Authors:  Korenori Ohtsubo; Michio Sata; Takumi Kawaguchi; Satoshi Morishige; Yuka Takata; Eijiro Oku; Rie Imamura; Ritsuko Seki; Michitoshi Hashiguchi; Koichi Osaki; Kazuaki Yakushiji; Taisuke Kanaji; Kohji Yoshimoto; Takato Ueno; Takashi Okamura
Journal:  Int J Hematol       Date:  2009-04-08       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.